Name: Name:Quetiapine sulfoxide
Brand: AABLOCKS
SKU: AA00BY3C
Rating: 90 (10 reviews)

Catalog No.: AA00BY3C

329216-63-9 | Quetiapine sulfoxide

Pack Size： 5mg

Purity： 95%

in stock

$482.00 $338.00

Pack Size： 25mg

Purity： 95%

in stock

$1,966.00 $1,377.00

Pack Size： 50mg

Purity： 95%

in stock

$3,493.00 $2,445.00

Pack Size： 100mg

Purity： 95%

in stock

$6,241.00 $4,369.00

Quantity

- +

Add to Card

Order Now

bulk Quotation Request

Technical Information

Catalog Number: AA00BY3C

Chemical Name: Quetiapine sulfoxide

CAS Number: 329216-63-9

Molecular Formula: C21H25N3O3S

Molecular Weight: 399.5065

MDL Number: MFCD08460237

SMILES: OCCOCCN1CCN(CC1)C1=Nc2ccccc2S(=O)c2c1cccc2

Properties

BP: 611.3°C at 760 mmHg

Form: Solid

MP: >51ºC (dec.)

Storage: Inert atmosphere;-20 ℃;

Complexity: 515

Covalently-Bonded Unit Count: 1

Defined Atom Stereocenter Count: 0

Defined Bond Stereocenter Count: 0

Formal Charge: 0

Heavy Atom Count: 28

Hydrogen Bond Acceptor Count: 7

Hydrogen Bond Donor Count: 1

Isotope Atom Count: 0

Rotatable Bond Count: 6

Undefined Atom Stereocenter Count: 1

Undefined Bond Stereocenter Count: 0

XLogP3: 0.9

Downstream Synthesis Route

1076199-40-0

4407-36-7

63157-81-3

111974-69-7

329216-63-9

[1]Koerber,Jochen;Loeffler,Stefan;Schollmeyer,Dieter;Nubbemeyer,Udo[Synthesis,2013,vol.45,#20,p.2875-2887]

1076199-40-0

4407-36-7

14371-10-9

111974-69-7

329216-63-9

[1]Koerber,Jochen;Loeffler,Stefan;Schollmeyer,Dieter;Nubbemeyer,Udo[Synthesis,2013,vol.45,#20,p.2875-2887]

Literature fold

Title: Behavioral approach to nondyskinetic dopamine antagonists: identification of seroquel.

Journal: Journal of medicinal chemistry20010201

Title: Remmerie B, et al. Comparison of Capillary and Venous Drug Concentrations After Administration of a Single Dose of Risperidone, Paliperidone, Quetiapine, Olanzapine, or Aripiprazole. Clin Pharmacol Drug Dev. 2016 Nov;5(6):528-537.

Title: Cross AJ, et al. Quetiapine and its metabolite norquetiapine: translation from in vitro pharmacology to in vivo efficacy in rodent models. Br J Pharmacol. 2016 Jan;173(1):155-66.